ArticleFrontiers in oncology2022

CNN1 Represses Bladder Cancer Progression and Metabolic Reprogramming by Modulating HIF-1α Signaling Pathway.

Zheng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.